351 related articles for article (PubMed ID: 28368409)
1. Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.
Bado I; Gugala Z; Fuqua SAW; Zhang XH
Oncogene; 2017 Aug; 36(32):4527-4537. PubMed ID: 28368409
[TBL] [Abstract][Full Text] [Related]
2. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer metastasis to the bone: mechanisms of bone loss.
Chen YC; Sosnoski DM; Mastro AM
Breast Cancer Res; 2010; 12(6):215. PubMed ID: 21176175
[TBL] [Abstract][Full Text] [Related]
4. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer.
Wu K; Feng J; Lyu F; Xing F; Sharma S; Liu Y; Wu SY; Zhao D; Tyagi A; Deshpande RP; Pei X; Ruiz MG; Takahashi H; Tsuzuki S; Kimura T; Mo YY; Shiozawa Y; Singh R; Watabe K
Nat Commun; 2021 Aug; 12(1):5196. PubMed ID: 34465793
[TBL] [Abstract][Full Text] [Related]
6. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
[TBL] [Abstract][Full Text] [Related]
7. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase.
Cox TR; Rumney RMH; Schoof EM; Perryman L; Høye AM; Agrawal A; Bird D; Latif NA; Forrest H; Evans HR; Huggins ID; Lang G; Linding R; Gartland A; Erler JT
Nature; 2015 Jun; 522(7554):106-110. PubMed ID: 26017313
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors alpha and beta in bone.
Khalid AB; Krum SA
Bone; 2016 Jun; 87():130-5. PubMed ID: 27072516
[TBL] [Abstract][Full Text] [Related]
9. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Receptors and Endometriosis.
Chantalat E; Valera MC; Vaysse C; Noirrit E; Rusidze M; Weyl A; Vergriete K; Buscail E; Lluel P; Fontaine C; Arnal JF; Lenfant F
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316608
[TBL] [Abstract][Full Text] [Related]
12. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.
Shanle EK; Hawse JR; Xu W
Biochem Pharmacol; 2011 Dec; 82(12):1940-9. PubMed ID: 21924251
[TBL] [Abstract][Full Text] [Related]
13. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.
Bartella V; Rizza P; Barone I; Zito D; Giordano F; Giordano C; Catalano S; Mauro L; Sisci D; Panno ML; Fuqua SA; Andò S
Breast Cancer Res Treat; 2012 Jul; 134(2):569-81. PubMed ID: 22622808
[TBL] [Abstract][Full Text] [Related]
15. Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha.
Imai Y; Kondoh S; Kouzmenko A; Kato S
Mol Endocrinol; 2010 May; 24(5):877-85. PubMed ID: 19910454
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a multi-target compound for estrogen receptor-positive (ER
Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondins in bone remodeling and metastatic bone disease.
Carminati L; Taraboletti G
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C980-C990. PubMed ID: 32936697
[TBL] [Abstract][Full Text] [Related]
18. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
[TBL] [Abstract][Full Text] [Related]
19. A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment.
Kang J; Choi YJ; Seo BY; Jo U; Park SI; Kim YH; Park KH
Sci Rep; 2019 Jun; 9(1):8726. PubMed ID: 31217507
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the expression of estrogen receptors in osteogenic cells isolated from hen medullary bone.
Hiyama S; Sugiyama T; Kusuhara S; Uchida T
Acta Histochem; 2009; 111(6):501-7. PubMed ID: 18835015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
